Augtyro (repotrectinib capsules) — Cigna
Solid tumors (NTRK gene fusion-positive)
Initial criteria
- Patient is age ≥ 12 years; AND
- Tumor is positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusion; AND
- Patient meets ONE of the following (i or ii):
- i. Tumor is locally advanced or metastatic; OR
- ii. Surgical resection of tumor will likely result in severe morbidity
Approval duration
1 year